Introduction
Pregnancy is a physiological condition in female. Many changes occur in pregnancy. During pregnancy hormonal changes include not only oestrogen and progesterone level but also other hormones like thyroid hormone 1 . The endocrine glands play very important role in the physiology of reproduction. During pregnancy, physiological alteration of various endocrine glands namely the pituitary, thyroid, parathyroid, adrenals and pancreas, show distinct physiological changes leading to increase in output of respective hormones. The basic purpose of these changes is to adjust the internal environment of the mother to meet the additional requirements impose by metabolic changes during pregnancy as well as to met the extra demands by the growing fetus 2 . Common thyroid diseases have a strong predominance in women of childbearing age. For this reason, assessment of thyroid function during pregnancy is very important. Proper diagnosis and treatment of thyroid dysfunction during pregnancy is important to avoid both fetal & maternal complications. Assessment of both hyper & hypothyroidism during pregnancy should be done with a careful measurement of TSH & free thyroid hormones 3 . Thyroid hormones are essential for normal growth and skeletal maturation. They potentiate the effect of growth hormone on the tissue. In hypothyroid children bone growth is slowed and epiphyseal closure is delayed 4 . Thyroid hormones have important roles in embryogenesis and fetal maturation 5 . In hypothyroidism mentation is slow and the CSF protein level is elevated. Thyroid hormones have marked effects on brain development and its deficiency affects the cerebral cortex, basal ganglia and cochlea. Consequently, thyroid hormones deficiency during development causes mental retardation, motor rigidity and deaf-mutism 4 . Thyroxine plays a very important role in the development and maturation of the central nervous system in utero and in the immediate post natal periods 6 . Mildly increased serum TSH levels during pregnancy might also increase the risk of fetal death. So, TSH measurement should be a routine screening for thyroid dysfunction before or during first trimester of pregnancy 7 . Currently FT 3 , FT 4 is abnormal, the FT 4 level is tested. If FT 4 is normal, the FT 3 level is tested for disorders 8 . The thyroid abnormalities during gestation suggests that screening for thyroid dysfunction in relation to pregnancy should be strongly considered. A free serum level is more accurate in detecting thyroid activity than a total serum level, which is affected by protein binding. Free T 3 & T 4 levels are not influenced by the degree of protein binding, which can be affected by numerous factors (illness, genetics, medications). So, FT 3 & FT 4 are the true markers of thyroid hormones biological activity 9 . So, the present study has been designed to asses the thyroid functional status by measuring FT 3 , FT 4 & TSH levels in pregnant women and to compare these values with the control group ( non-pregnant ). The study result will help us to determine whether the thyroid function tests are to be included as a routine test during antenatal check-up or not.
Materials and Methods
This Cross-sectional analytical study was done in the Department of Physiology in Dhaka Medical College, Dhaka from July 2006-June 2007. Permission was taken from the concerned Departments & authorities after getting recommendation of ethical committee. Informed written consent was taken from all the study subjects after full explanation of nature and purpose of the study. Total 50 subjects of age ranged from 18-40 years were selected from the out patient department of urban primary health care project at Mirpur, Dhaka, who belong to low socioeconomic status. Out of total 50 subjects 30 were pregnant women(Group-A) and 20 were non-pregnant women of child bearing age (Group-B). Group A was again subdivided in to three sub-groups (A 1 -Pregnant women of first trimester, A 2 -Pregnant women of second trimester, A 3 -Pregnant women of third trimester). Estimation of serum FT 3 and FT 4 of study subjects by RIA and estimation of serum TSH of study subjects by IRMA at center for nuclear medicine & ultrasound, DMCH campus, Dhaka were taken as parameters of both groups. Study subjects were selected considering inclusion and exclusion criteria. Inclusion criteria were -a)Age 18 -40 years b) Pregnant women c) No clinical evidence of thyroid disease.
Exclusion criteria were -a) Subject with pregnancy complication b) Subject with Diabetes Mellitus, renal or hepatic disorders c) Subject received lipiodol injection or any other medication known to influence thyroid function. All the subjects were explained about the aim and objective of this study. The test procedure was briefed and demonstrated. Written consent was taken before performing the test. Detailed history of each subject was obtained by using a pretested questionnaire. Clinical examination of these subjects was done before taking blood samples. The sample was selected randomly according to the inclusion & exclusion criteria. With all aseptic precautions 5ml venous blood 2015 Volume 27 Number 02 02 was drawn from the ante-cubital vein in a disposable syringe and then blood was immediately transferred to a dry clean test tube and allowed to clot. After clot formation, serum was separated by centrifuging the blood at 3000 rpm for 5 minutes. Serum was kept in micro centrifuge tube after labeling and was preserved at-40ºC until analysis. All data were checked and edited after collection. Then the data were entered into computer and analyzed with the help of SPSS 12 programme and significance test were done by unpaired Student's 't' test.
Results
The means ( SD) of serum FT 3 levels were 6.36 1.16 pmol/L and 6.38 1.38 pmol/L in group A (Study) and group B (control) respectively. The difference of means ( SD) of serum FT 3 levels were not significant (p>0.05) between group A and B. (table I) The means ( SD) of serum TSH levels were 0.96 0.96 mIu/L and 1.27 0.86 mIu/L in group A (study) and group B (control) respectively. The difference of means ( SD) of serum TSH levels were not significant (p>0.05) between group A and B. (table III) The results are expressed as follows:
1. Serum FT 3 : p mol 2. Serum FT 4 : p mol/L 3. Serum TSH : mIu/L Results were expressed as mean ± SD (Standard deviation). The statistical significance of difference between the groups were evaluated by using Student's 't' test in case of control and study groups and by ANOVA test in case of subgroups (study). 
Discussion
The present study has been undertaken to evaluate the changes of serum FT 3 , FT 4 and TSH levels in pregnant women and non pregnant women. For that purpose serum FT 3 , FT 4 and TSH levels were estimated in pregnant and non pregnant women.
Total 50 subjects age ranged from 18-40 years were selected, of whom 30 were pregnant women (study group) and 20 were non pregnant women (control group). The pregnant women were again grouped into three groups according to the duration of pregnancy. The subjects were from low socio economic status and were free from disease. Pulse rate, resting blood pressure of all the subjects were recorded before collection of blood.
In this study the mean serum FT 3 levels were 6.36 1.16 p mol/L and 6.38 1.38 p mol/L in case and control group respectively and mean serum FT 4 levels were 20.25 4.77 p mol/L and 19.39 8.17 p mol/L in pregnant and non pregnant women respectively. The difference of means ( SD) of serum FT 3 and FT 4 levels were not statistically significant (p>0.05).
These findings are also consistent with those reported by Corinne et. al (1999) 3 . Some studies have shown a decrease in free hormones during pregnancy 10 . Pregnant women on average had lower free hormone concentrations at term than non pregnant women and studies have shown that serum FT 3 and FT 4 are about 25% lower in women at delivery than non 12 . However most pregnant women (>78%) remain within the same reference interval as non pregnant women 13 . Serum free T 4 and T 3 levels were significantly elevated throughout the pregnancy in comparison with non pregnant. FT 4 concentration was elevated after 10 weeks of pregnancy and FT 3 concentration was elevated at 13-20 weeks 14 . During the first 5 weeks of pregnancy mean serum free T 4 and free T 3 levels were 50% higher than in non pregnant women or women during the third trimester. FT 4 was increased significantly throughout the first trimester but FT 3 was significantly above control values only during the first 5 weeks. FT 4 and FT 3 levels decreased to control levels in the third trimester. These changes in FT 4 and FT 3 concentrations are consistent with a weak thyrotropic action of Human Chorionic Gonadotropin hormone (HCG), which attained maximum concentrations early in the first trimester and then decreased markedly in the second and third trimester 12 .
In present study the mean ( SD) serum TSH levels were 0.96 0.96 mIu/L and 1.27 0.86 mIu/L in experimental and control group respectively. The difference of means ( SD) of serum TSH levels were not statistically significant (p>0.05).This finding is also consistent with those reported by Corinne et. al (1999) 3 . TSH levels are significantly lower at 9-12 weeks compared with the rest of the pregnancy. HCG may be a weak thyroid stimulator that causes a modest rise in free thyroid hormones early in the pregnancy which in turn causes a modest reduction in pituitary TSH secretion 14 . High concentration of HCG present in the first trimester of pregnancy causes the reduction in TSH level 15 . TSH level is decreased in the first trimester and then return to normal throughout the duration of pregnancy. Normal TSH level throughout the pregnancy indicates thyroid is functioning normally 16 . From the statistical analysis of the results obtained in the present study and their comparison with those of published reports, it may be concluded that there is no change of serum FT 3 , FT 4 and TSH levels in pregnancy. So, the study result will help us to determine that the "Thyroid function tests" are not necessary to include as a routine test during antenatal check-up.
